Clinical Roundup ACCC establishes projects to address cancer screening and care challenges in Appalachia May 13, 2022Vol.48 No.19
Conversation with The Cancer Letter FDA’s Lola Fashoyin-Aje: It’s time to increase racial diversity in trials—here’s a draft guidance for how this can be done May 06, 2022Vol.48 No.18By Matthew Bin Han Ong
Clinical Roundup Uterine cancer deaths are rising in the U.S.; rates highest in Black women May 06, 2022Vol.48 No.18
Clinical Roundup ACS studies find increase in use of PBT in cancer, with significant racial disparities May 06, 2022Vol.48 No.18
Clinical Roundup ACS study shows medical financial hardship increases mortality risk for cancer survivors May 06, 2022Vol.48 No.18
Clinical Roundup ACS study: AYA cancer survivors face increased cancer incidence and mortality risk May 06, 2022Vol.48 No.18
Clinical Roundup Racial and ethnic disparities persist for early-stage breast cancer detection and survival May 06, 2022Vol.48 No.18
LGBTQ+ Cancer Symposium aims to increase visibility of patients of all genders and sexualities April 29, 2022Vol.48 No.17By Alice Tracey
Regulatory News As part of Cancer Moonshot, FDA seeks to prohibit menthol cigarettes, flavored cigars April 29, 2022Vol.48 No.17By Paul Goldberg
In Brief UC Davis Comprehensive Cancer Center establishes Center for Advancing Cancer Health Equity April 29, 2022Vol.48 No.17
